Vadilal Enterprises Intrinsic Value

Vadilal Enterprises (VADILENT) median intrinsic value is ₹3920.00 from 2 valuation models (range ₹1960–₹3920), vs current price ₹9800.00 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse VADILENT complete financial statements for revenue, profit, balance sheet and cash flow data.

Current Stock Price
₹9800.00
Primary Intrinsic Value
₹1960.00
Market Cap
₹980.0 Cr
-60.0% Downside
Median Value
₹3920.00
Value Range
₹1960 - ₹3920
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

VADILENT Valuation Methods Summary — DCF, Graham Number & P/E

Vadilal Enterprises intrinsic value across 2 models vs current price ₹9800.00 — upside/downside and value range per method. For current market price and key ratios, visit VADILENT share price.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹1960.00 ₹1764.00 - ₹2156.00 -80.0% Book Value/Share: ₹40.00, P/B: 1.0x
Simple DCF (5Y) dcf ₹3920.00 ₹3136.00 - ₹4704.00 -60.0% CF Growth: 15.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

VADILENT Intrinsic Value vs Market Price — All Valuation Models

Vadilal Enterprises fair value range ₹1960–₹3920 vs current market price ₹9800.00 across 2 valuation models. Also explore VADILENT share price data to track price trends across different timeframes.

VADILENT Intrinsic Value Analysis — Undervalued or Overvalued?

Vadilal Enterprises median intrinsic value ₹3920.00, current price ₹9800.00 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.

What is the intrinsic value of VADILENT?

Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Vadilal Enterprises (VADILENT) is ₹3920.00 (median value). With the current market price of ₹9800.00, this represents a -60.0% variance from our estimated fair value.

The valuation range spans from ₹1960.00 to ₹3920.00, indicating ₹1960.00 - ₹3920.00.

Is VADILENT undervalued or overvalued?

Based on our multi-method analysis, Vadilal Enterprises (VADILENT) appears to be trading above calculated value by approximately 60.0%.

VADILENT Financial Health — Key Ratios vs Industry Benchmarks

Vadilal Enterprises financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 19.50 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity

VADILENT Cash Flow Quality — Operating & Free Cash Flow

Vadilal Enterprises operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2016 ₹28 Cr ₹20 Cr Positive Free Cash Flow 8/10
March 2015 ₹15 Cr ₹9 Cr Positive Free Cash Flow 8/10